Evidence map›Paper›PMID 34900568›Full record

Trial reportGlobal heart2021

Monitoring Study Participants and Implementation with Phone Calls to Support Hypertension Control During the COVID-19 Pandemic: The Case of a Multicomponent Intervention Trial in Guatemala.

Diego Hernández-Galdamez, Kristyne Mansilla, Ana Lucía Peralta, Javier Rodríguez-Szaszdi, Juan Manuel Ramírez, Dina Roche, Pablo Gulayin, Manuel Ramirez-Zea, Jiang He, Vilma Irazola and 1 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Global heart, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. "International journal of environmental research and public health · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Diego Hernández-GaldamezINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, GT.
Kristyne MansillaINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, GT.
Ana Lucía PeraltaINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, GT.
Javier Rodríguez-SzaszdiINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, GT.
Juan Manuel RamírezINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, GT.
Dina RocheINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, GT.
Pablo GulayinInstitute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, AR.
Manuel Ramirez-ZeaINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, GT.
Jiang HeTulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, US.
Vilma IrazolaInstitute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, AR.
Meredith P FortColorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, US.
Institute of Nutrition of Central America and Panama · GTColorado School of Public Health · USInstituto de Efectividad Clínica y Sanitaria · ARTulane University · US

Funding

IMPlementation to Achieve Clinical Transformation (IMPACT): The Colorado Training ProgramK12HL137862 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GLASGOW, RUSSELL E, HAVRANEK, EDWARD PAUL · 2017 to 2021
$2.9M
Implementing a Multicomponent Intervention to Improve Hypertension Control in Central AmericaU01HL138647 · NHLBI · INSTITUTE/NUTRITION/CENT/AMERICA/PANAMA · PI HE, JIANG, RAMIREZ-ZEA, MANUEL · 2017 to 2021
$1.6M
NHLBI NIH HHS K12 HL137862NHLBI NIH HHS U01 HL138647
6 · The paper itself

Abstract

Background: The COVID-19 pandemic presents a challenge to health care for patients with chronic diseases, especially hypertension, because of the important association and increased risk of these patients with a severe presentation of COVID-19 disease. The Guatemalan Ministry of Health has been implementing a multi-component program aimed at improving hypertension control in rural communities since 2019 as a part of an intervention research cluster randomized trial. When the first cases of COVID-19 were reported (March 13, 2020) in Guatemala, our study paused all study field activities, and began monitoring participants through phone calls. The objective of this paper is to describe the approach used to monitor study participants during the COVID-19 pandemic and compare data obtained during phone calls for intervention and control group participants. Methods: We developed a cross-sectional study within the HyTREC (Hypertension Outcomes for T4 Research within Lower Middle-Income Countries) project 'Multicomponent Intervention to Improve Hypertension Control in Central America: Guatemala' in which phone calls were made to participants from both intervention and control groups to monitor measures important to the study: delivery of antihypertensive medications in both groups, receipt of coaching sessions and use of a home blood pressure monitor by intervention group participants, as well as reasons that they were not implemented. Results: Regarding the delivery of antihypertensive drugs by the MoH to participants, those in the intervention group had a higher level of medication delivery (73%) than the control group (51%), p<0.001. Of the total participants in the intervention group, 62% had received at least one health coaching session in the previous three months and 81% used a digital home blood pressure monitor at least twice a week. Intervention activities were lower than expected due to restricted public transportation on top of decreased availability of health providers. Conclusion: In Guatemala, specifically in rural settings, access to antihypertensive medications and health services during pandemic times was impaired and less than expected, even after accounting for the program's implementation activities and actions.

Indexed as

COVID-19HypertensionCross-Sectional StudiesGuatemalaHumansPandemicsSARS-CoV-2Cardiovascular DiseasesCovid-19HypertensionImplementation SciencemHealthNon-communicable Diseases

Identifiers

PMID34900568
PMCPMC8622336
OpenAlexW3216927469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.